Login to Your Account

AstraZeneca Reorganizes, Cuts 1,600 jobs, Ups the Ante in UK

By Nuala Moran
Staff Writer

Tuesday, March 19, 2013
LONDON – AstraZeneca plc is once again taking the ax to its R&D operations, announcing plans to relocate 2,500 roles and cut about 1,600 jobs, mainly in the UK and U.S., as it consolidates discovery and development in Cambridge, UK; Gaithersburg, Maryland; and Mölndal, near Gothenburg, in Sweden.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription